A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Clinical trial NCT06850051 · COMPLETED

Trial details

NCT number: NCT06850051
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Influenza Vaccination Respiratory Syncytial Virus Vaccination Parainfluenza Vaccination Human Metapneumovirus Vaccination

Start date: 2025-03-19
Primary completion: 2025-12-11
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.